Tommy Tong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tommy Tong has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Ema T Crooks
Torrey Pines Institute for Molecular Studies, San Diego, CA 92121, USA
1 shared publication - Guido Vanham
Department of Microbiology, Institute of Tropical Medicine, Antwerp, Belgium
1 shared publication - James M. Binley
Torrey Pines Institute for Molecular Studies, San Diego, CA 92121, USA
1 shared publication - Katrijn Grupping
Institute of Tropical Medicine, Antwerp, Belgium
1 shared publication - Kevin K. Arien
Virology Unit, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium
1 shared publication - Loïc Martin
†CEA, iBiTecS, Service d’Ingénierie Moléculaire des Protéines, F-91191 Gif-sur-Yvette, France
1 shared publication
Latest Publications
- Open Access
- 1 February 2013
- Published by Springer Nature in Retrovirology
- Vol. 10 (1) , 12
M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding
Background: HIV-1 infected cells can establish new infections by crossing the vaginal epithelia and subsequently producing virus in a milieu that avoids the high microbicide concentrations of the vaginal lumen. Findings: To address this problem, here, we report that pretreatment of HIV-infected peripheral blood mononuclear cells (PBMCs) with a 27 amino acid CD4-mimetic, M48U1, causes dramatic and prolonged reduction of infectious virus output, due to its induction of gp120 shedding. Conclusions: M48U1 may, therefore, be valuable for prophylaxis of mucosal HIV-1 transmission.
- 1 February 2013
- Published by Springer Nature in Retrovirology
- Vol. 10 (1) , 12
Open AccessM48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding
Background: HIV-1 infected cells can establish new infections by crossing the vaginal epithelia and subsequently producing virus in a milieu that avoids the high microbicide concentrations of the vaginal lumen. Findings: To address this problem, here, we report that pretreatment of HIV-infected peripheral blood mononuclear cells (PBMCs) with a 27 amino acid CD4-mimetic, M48U1, causes dramatic and prolonged reduction of infectious virus output, due to its induction of gp120 shedding. Conclusions: M48U1 may, therefore, be valuable for prophylaxis of mucosal HIV-1 transmission.